JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yoshio Ootaki
Masahiro Yamaguchi
Naoki Yoshimura
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ootaki, Y.
Right arrow Articles by Hasegawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ootaki, Y.
Right arrow Articles by Hasegawa, T.
Related Collections
Right arrow Extracorporeal circulation

J Thorac Cardiovasc Surg 2004;127:953-958
© 2004 The American Association for Thoracic Surgery


Surgery for congenital heart disease

Efficacy of a criterion-driven transfusion protocol in patients having pediatric cardiac surgery

Yoshio Ootaki, MD, PhDa,*, Masahiro Yamaguchi, MD, PhDa, Naoki Yoshimura, MD, PhDa, Shigeteru Oka, MD, PhDa, Masahiro Yoshida, MDa, Tomomi Hasegawa, MDa

a Department of Cardiothoracic Surgery, Kobe Children's Hospital, Kobe, Japan

Received for publication April 1, 2003; revisions received June 3, 2003; revisions received June 19, 2003; accepted for publication July 10, 2003.

* Address for reprints: Yoshio Ootaki, MD, Department of Cardiothoracic Surgery, Kobe Children's Hospital, 1-1-1 Takakuradai, Suma-ku, Kobe, Hyogo 654-0081, Japan
y.ootaki{at}nifty.ne.jp

OBJECTIVES: Low-hematocrit bypass is one technique used to prevent allogeneic transfusion during cardiopulmonary bypass. The purpose of this study is to determine the efficacy of a criterion-driven transfusion protocol and the effect of low-hematocrit bypass with moderate hypothermia in pediatric cardiac surgery.

METHODS: Seventy-five children who underwent cardiopulmonary bypass with low-hematocrit bypass for repair of congenital heart disease were studied. Criteria for red blood cell transfusion included anemia with a hematocrit level of less than 15% during bypass and 20% after bypass. During cardiopulmonary bypass, venous oxygen saturation, hematocrit values, and regional cerebral oxygenation were continuously monitored. Arterial lactate levels were measured postoperatively.

RESULTS: All patients had an uncomplicated perioperative course, and no perioperative death occurred. Twenty-two patients (29.3%) received a transfusion, and 53 (70.7%) patients did not. The hematocrit levels before and after modified ultrafiltration in the transfused group (21.6 ± 5.5%, 26.6 ± 6.5%) were significantly higher than those in the nontransfused group (18.9 ± 3.7%, 23.1 ± 4.1%) (P < .05). There was no significant difference between the group's arterial lactate levels immediately after admission to the intensive care unit and 1 day after the operation. The arterial lactate levels 6 hours after the admission to the intensive care unit for the nontransfused patients were higher than with the transfused patients (4.3 ± 3.0 versus 2.5 ± 1.5 mmol/L, (P < .05). For arterial lactate level, the relation with patients' weight had the highest correlation (R = 0.678, P < .0001).

CONCLUSIONS: A criterion-driven transfusion program can be effective, and low-hematocrit bypass with a hematocrit value below 20% may affect lactate production or clearance from the body.





This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Miyaji, S. Kohira, T. Miyamoto, K. Nakashima, H. Sato, K. Ohara, and H. Yoshimura
Pediatric cardiac surgery without homologous blood transfusion, using a miniaturized bypass system in infants with lower body weight
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 284 - 289.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. A. Jonas
Hematocrit trial
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1200 - 1200.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Ootaki, M. Yamaguchi, and N. Yoshimura
Reply to the Editor
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1201 - 1202.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.